CID 86267612

Vimseltinib

Structural Information

Molecular Formula
C23H25N7O2
SMILES
CC1=C(C=CC(=N1)C2=CN=C(N(C2=O)C)NC(C)C)OC3=CC(=NC=C3)C4=CN(N=C4)C
InChI
InChI=1S/C23H25N7O2/c1-14(2)27-23-25-12-18(22(31)30(23)5)19-6-7-21(15(3)28-19)32-17-8-9-24-20(10-17)16-11-26-29(4)13-16/h6-14H,1-5H3,(H,25,27)
InChIKey
TVGAHWWPABTBCX-UHFFFAOYSA-N
Compound name
3-methyl-5-[6-methyl-5-[2-(1-methylpyrazol-4-yl)pyridin-4-yl]oxypyridin-2-yl]-2-(propan-2-ylamino)pyrimidin-4-one
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

2
References

191
Patents

431.20697 Da
Monoisotopic Mass

1.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 432.21425 206.2
[M+Na]+ 454.19619 222.5
[M+NH4]+ 449.24079 210.1
[M+K]+ 470.17013 217.7
[M-H]- 430.19969 211.2
[M+Na-2H]- 452.18164 215.6
[M]+ 431.20642 209.9
[M]- 431.20752 209.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe